HEALTHCARE
Governance-native AI infrastructure for clinical, pharma, and biological compute
Constitutional RuntimeWho this is for
Healthcare CTOs and CIOs, clinical informatics leaders, pharma R and D governance owners, medical device compliance teams, and researchers operating at the boundary of AI and biology. If your organization deploys AI where a wrong answer has clinical, regulatory, or human consequence, the governance surface belongs upstream of the model.
- Clinical informatics and decision support integration teams
- Pharma R and D governance and pharmacovigilance
- Medical device software of a medical device teams
- Regulated industries
- Research groups working with biological compute substrates
Capability surface
Constitutional runtime
The PRAXIS 7-Gate pipeline enforces governance on every AI action. It stops when unsure. Evidence is mandatory. Defaults deny rather than guess. Clinical and pharma workflows inherit this posture by construction, not by policy overlay.
Evidence control layer
Every action, decision, and generation is recorded to a tamper-evident, SHA-256 hash-chained evidence store. Regulator-ready trace by default, not retrofit. Sealed receipts survive substrate replacement.
Substrate independence
Governance is defined above the substrate. Silicon, GPU, TPU, or biological compute (see the AIxBio cross-reference below). The same constitutional rules bind, the same evidence chain accumulates, the same human authority holds.
Regulatory alignment
Deterministic governance maps to HIPAA administrative safeguards, EU AI Act high-risk requirements, GDPR data-subject controls, and Good Machine Learning Practice for medical device software. SOC 2 self-certified. ISO 42001 readiness-mapped.
ASI-ready architecture
Designed for a world where AGI-class and ASI-class systems exist. Bounded autonomy, separation of duties, and human-sovereign gates on all consequential actions. ETHRAEON does not claim to be AGI or ASI; it governs systems that may become so.
Sovereign deployment
On-premise sovereign deployment for institutions that cannot exfiltrate patient data or research IP to a vendor cloud. Evidence store and constitutional runtime run inside the boundary you already trust.
Biological compute cross-reference
The ETHRAEON research paper AIxBio Plausibility documents why the constitutional runtime and evidence control layer applies not only to silicon substrates but to biological compute as well. As organoid intelligence, wetware, and hybrid substrates move from research to production, the governance surface must travel with them.
This is ETHRAEON's substrate-independence moat: the same constitutional rules bind a GPU cluster, a clinical decision support system, or a biological compute substrate. Evidence accumulates in the same hash-chained store. Human authority holds across the boundary.
Proof surface
ETHRAEON runs its own operations under constitutional governance. 300 plus production surfaces, 700 plus governance directives executed and evidenced, a hash-chained evidence store, and a substrate registry that reports live status. The infrastructure is the demonstration.
Engagement
Healthcare engagements start with a governance briefing scoped to your regulatory posture and deployment boundary. The briefing produces a written architecture assessment and a deployment path proposal. From there: pilot, evidenced production deployment, or sovereign on-premise install.
Portfolio anchors
ETHRAEON is a constitutional runtime and evidence control layer. Portfolio posture: 16 U.S. provisional filings, 73 specifications, 9 families. Public claims are calibrated. AGI-class and ASI-class positioning is architectural, not an achievement claim.